GSK delivers strong 2023 performance and upgrades growth …
https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-2023-performance-and-upgrades-growth-outlooks/
WEBJan 31, 2024 · Emma Walmsley, Chief Executive Officer, GSK: “GSK delivered excellent performance in 2023, with clear highlights being the exceptional launch of Arexvy and continued progress in our pipeline. We are now planning for at least 12 major launches from 2025, with new Vaccines and Specialty Medicines for infectious diseases, HIV, …
DA: 13 PA: 71 MOZ Rank: 41